JP2000229995A - Method and apparatus for regenerating protein - Google Patents
Method and apparatus for regenerating proteinInfo
- Publication number
- JP2000229995A JP2000229995A JP11033640A JP3364099A JP2000229995A JP 2000229995 A JP2000229995 A JP 2000229995A JP 11033640 A JP11033640 A JP 11033640A JP 3364099 A JP3364099 A JP 3364099A JP 2000229995 A JP2000229995 A JP 2000229995A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- regenerating
- solution
- denatured protein
- inner cylinder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 49
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 48
- 230000001172 regenerating effect Effects 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 25
- 239000012460 protein solution Substances 0.000 claims abstract description 35
- 238000011069 regeneration method Methods 0.000 claims abstract description 27
- 230000008929 regeneration Effects 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 239000012528 membrane Substances 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 12
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005192 partition Methods 0.000 claims description 5
- 239000000919 ceramic Substances 0.000 claims description 4
- 230000004907 flux Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000013459 approach Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 5
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000003000 inclusion body Anatomy 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 239000012557 regeneration buffer Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013578 denaturing buffer Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、立体構造に異常の
ある蛋白質の再生方法及び再生装置に関するものであ
る。[0001] The present invention relates to a method and apparatus for regenerating a protein having an abnormal three-dimensional structure.
【0002】[0002]
【従来の技術】遺伝子工学の発展により、有用蛋白質を
その蛋白質をコードする遺伝子を微生物等に組み込むこ
とにより生産することが可能となった。その生産法とし
ては、有用蛋白質を菌体内に生産させる方法と、菌体外
に分泌させる方法がある。前者の方法では、しばしば菌
体内にインクルージョンボディと呼ばれる封入体の形で
有用蛋白質が蓄積されることがある。このインクルージ
ョンボディとなった蛋白質のアミノ酸配列は天然の蛋白
質と同じであるが、立体構造が天然のものとは異なって
いるために不活性体となっている。この不活性蛋白質を
活性体として利用するためには、その蛋白質を一旦可溶
化したうえで正しい立体構造に折り畳む作業(リフォー
ルディング)が必要である。本明細書ではこのリフォー
ルディングを蛋白質の再生と表現する。2. Description of the Related Art The development of genetic engineering has made it possible to produce useful proteins by incorporating genes encoding the proteins into microorganisms and the like. As a production method, there are a method of producing a useful protein in the cells and a method of secreting the useful protein outside the cells. In the former method, useful proteins are sometimes accumulated in the form of inclusion bodies called inclusion bodies in the cells. The amino acid sequence of this inclusion body protein is the same as that of the natural protein, but is inactive because the tertiary structure is different from that of the natural protein. In order to utilize this inactive protein as an active form, it is necessary to solubilize the protein once and then fold it into a correct three-dimensional structure (refolding). This refolding is referred to herein as protein regeneration.
【0003】インクルージョンボディとなった不活性蛋
白質を再生する方法としては、例えば特開昭59−16
1312号等の方法が既に知られている。よく用いられ
る可溶化方法は、高濃度の尿素または塩酸グアニジン溶
液を用い、ジスルフィド結合を持つものにはメルカプト
エタノールやジチオスレイトール等の還元剤で還元する
ことで可溶化する。このようにして可溶化された蛋白質
(変性蛋白質)を酸化及び還元型グルタチオンを用いて
得られる最適な酸化還元条件下で希釈するか、適切な緩
衝液で希釈もしくは透析することで蛋白質の再生が可能
となる。A method for regenerating an inactive protein that has become an inclusion body is disclosed in, for example, JP-A-59-16.
No. 1312 is already known. A frequently used solubilization method is to use a high-concentration urea or guanidine hydrochloride solution, and to solubilize those having a disulfide bond by reducing with a reducing agent such as mercaptoethanol or dithiothreitol. Protein regeneration can be achieved by diluting the solubilized protein (denatured protein) under optimal redox conditions obtained using oxidized and reduced glutathione, or by diluting or dialyzing with an appropriate buffer. It becomes possible.
【0004】ところで、この変性蛋白質の再生において
大きな障害となるのが蛋白質分子の凝集である。この凝
集とは、変性剤により一本鎖となった蛋白質が活性を持
った構造に巻き戻るまでの間に中間体が存在し、その中
間体が疎水性相互作用、ジスルフィド結合、静電気的相
互作用などによって分子間または分子内で誤った結合を
し、不活性で不溶性の凝集体になることである。この凝
集は変性蛋白質濃度が高いほど多く発生する。つまり高
い再生効率を達成するには、変性蛋白質濃度を低くする
必要があることが知られている(特開昭61−5021
67号)。しかし低濃度にするためには大量の処理量が
必要となり、時間や設備コストが余分に必要となる。従
ってできるだけ高い濃度で、しかも高い再生効率を達成
することが望まれている。[0004] A major obstacle to regeneration of the denatured protein is the aggregation of protein molecules. This aggregation means that an intermediate exists before the protein, which has become single-stranded by the denaturing agent, rewinds to an active structure, and the intermediate forms a hydrophobic interaction, a disulfide bond, and an electrostatic interaction. Incorrect aggregates between molecules or within molecules due to, for example, an inert and insoluble aggregate. This aggregation occurs more as the denatured protein concentration is higher. That is, in order to achieve high regeneration efficiency, it is known that it is necessary to lower the concentration of denatured protein (Japanese Patent Application Laid-Open No. Sho 61-5021).
No. 67). However, in order to reduce the concentration, a large amount of processing is required, and additional time and equipment costs are required. Therefore, it is desired to achieve as high a concentration as possible and high regeneration efficiency.
【0005】なお、従来の代表的な再生方法としては、
処理槽中に所定量の再生液を入れておき、その中に変性
蛋白質液を一度に加えて反応させる回分法と、変性蛋白
質液を何回かに分割して加える半回分法がある。しかし
回分法では上記したとおり変性蛋白質濃度を高くすると
再生効率が低下し、逆に変性蛋白質濃度を低くすると大
型の処理槽が必要となる。[0005] In addition, as a conventional typical reproducing method,
There are a batch method in which a predetermined amount of a regenerating solution is put in a treatment tank, and a denatured protein solution is added thereto at once, and a reaction is performed, and a semi-batch method in which the denatured protein solution is added in several portions. However, in the batch method, as described above, when the concentration of the denatured protein is increased, the regeneration efficiency is reduced. On the contrary, when the concentration of the denatured protein is reduced, a large processing tank is required.
【0006】これに対して半回分法では、最終的な変性
蛋白質濃度に達するまでに低濃度の状態で再生反応が進
行するため、回分法よりも高い再生効率を得ることがで
きる。しかし半回分法は連続処理が行えないために、工
業的プロセスに適用するうえで種々の不便がある。On the other hand, in the semi-batch method, the regeneration reaction proceeds in a low concentration state until the final denatured protein concentration is reached, so that a higher regeneration efficiency can be obtained than in the batch method. However, the semi-batch method has various inconveniences when applied to industrial processes because continuous processing cannot be performed.
【0007】[0007]
【発明が解決しようとする課題】本発明は上記した従来
の問題点を解決し、半回分法に匹敵する高い再生効率を
達成することができ、しかも連続処理を可能とした蛋白
質の再生方法及び再生装置を提供するためになされたも
のである。DISCLOSURE OF THE INVENTION The present invention solves the above-mentioned conventional problems and provides a method for regenerating a protein capable of achieving a high regenerating efficiency comparable to the semi-batch method and enabling continuous processing. This is to provide a playback device.
【0008】[0008]
【課題を解決するための手段】上記の課題を解決するた
めになされた本発明の蛋白質の再生方法は、反応槽の内
部に再生液を流しながら、この反応槽中に変性蛋白質液
を、その濃度が下流側に行くほど次第に高くなるように
多数点から加えることを特徴とするものである。また上
記の課題を解決するためになされた本発明の蛋白質の再
生装置は、変性蛋白質液が供給される外筒の内部に、変
性蛋白質液を透過させることができる膜よりなる内筒を
設けるとともに、この内筒の一端に再生液の供給口をま
た他端に取り出し口を設け、さらにこの内筒の内部に再
生液を流すための仕切り板を配置したことを特徴とする
ものである。According to the method for regenerating a protein of the present invention, which has been made to solve the above-mentioned problems, a denatured protein solution is introduced into a reaction vessel while flowing the regenerating solution inside the reaction vessel. It is characterized in that the concentration is added from a number of points so that the concentration gradually increases toward the downstream side. In addition, the protein regenerating apparatus of the present invention made in order to solve the above-mentioned problem is provided with an inner cylinder made of a membrane through which a denatured protein solution can pass, inside an outer cylinder to which a denatured protein solution is supplied. In addition, a supply port for the regenerating liquid is provided at one end of the inner cylinder, a take-out port is provided at the other end, and a partition plate for flowing the regenerating liquid is disposed inside the inner cylinder.
【0009】本発明の蛋白質の再生方法によれば、反応
槽の内部を流れる再生液中に、変性蛋白質液をその濃度
が下流側に行くほど次第に高くなるように多数点より加
えるため、入口部分の低濃度域において高効率の再生が
可能となる。しかも従来法とは異なり連続生産が可能と
なる。また本発明の装置によれば、変性蛋白質液を透過
させることができる膜よりなる内筒で処理槽を構成し、
その内部をプラグフローで流れる再生液中に周囲より変
性蛋白質液を透過させるようにしたので、変性蛋白質液
を反応槽のほぼ全長にわたり連続的に加えることができ
る。そのため高効率の再生が可能となる。According to the protein regeneration method of the present invention, the denatured protein solution is added to the regenerating solution flowing inside the reaction tank from a number of points so that the concentration gradually increases toward the downstream side. , High-efficiency regeneration is possible in the low concentration range. Moreover, unlike the conventional method, continuous production becomes possible. According to the apparatus of the present invention, the treatment tank is constituted by an inner cylinder made of a membrane through which a denatured protein solution can pass,
Since the denatured protein solution is allowed to permeate through the inside of the regenerating solution flowing through the plug flow from the surroundings, the denatured protein solution can be continuously added over substantially the entire length of the reaction tank. Therefore, high-efficiency reproduction becomes possible.
【0010】[0010]
【発明の実施の形態】以下に本発明の好ましい実施形態
を示す。図1は請求項1の蛋白質の再生方法を実施する
ための再生装置を示す断面図であり、1は水平に設置さ
れた外筒、2はその中心に配置された反応槽となる内筒
である。外筒1と内筒2との間には、変性蛋白質液の供
給口3を通じて変性蛋白質液が供給される。また反応槽
である内筒2の内部には、その一端に設けられた再生液
の供給口4を通じて再生液が供給される。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Preferred embodiments of the present invention will be described below. FIG. 1 is a cross-sectional view showing a regenerating device for carrying out the method for regenerating a protein according to claim 1, wherein 1 is an outer cylinder installed horizontally, and 2 is an inner cylinder serving as a reaction tank arranged at the center thereof. is there. A denatured protein solution is supplied between the outer cylinder 1 and the inner cylinder 2 through a supply port 3 for the denatured protein liquid. A regenerating liquid is supplied into the inner cylinder 2 serving as a reaction tank through a regenerating liquid supply port 4 provided at one end thereof.
【0011】供給口4から供給された再生液は、他端の
取り出し口5に向かって内筒2の内部をプラグフローで
流れて行く。このプラグフローとは押し出し流れとも呼
ばれ、流れ方向には液の混合が生じないような流れであ
る。このプラグフローを発生させるために、内筒2の内
部には仕切り板6を備えた回転軸7が設けられている。
この回転軸7には攪拌羽根8が設けられているため、再
生液は流れ方向に垂直な同一断面内では均一に攪拌混合
されるが、仕切り板6により流れ方向(水平方向)には
混合されないようになっている。The regenerating liquid supplied from the supply port 4 flows through the inside of the inner cylinder 2 toward the outlet port 5 at the other end by a plug flow. This plug flow is also called an extrusion flow, and is a flow in which liquid does not mix in the flow direction. In order to generate this plug flow, a rotating shaft 7 having a partition plate 6 is provided inside the inner cylinder 2.
Since the rotating shaft 7 is provided with the stirring blades 8, the regenerating liquid is uniformly stirred and mixed in the same cross section perpendicular to the flow direction, but is not mixed in the flow direction (horizontal direction) by the partition plate 6. It has become.
【0012】内筒2は変性蛋白質液を透過させることが
できる膜により構成されている。この実施形態において
は、円筒状のセラミック膜が用いられており、変性蛋白
質液を膜面全体の無数の点から均一なフラックスで内筒
2の内部に注入することができる構造となっている。し
かし必ずしも膜面全体から変性蛋白質液を透過させる必
要はなく、粘性の大きい変性蛋白質液を目詰まりさせる
ことなく注入することができる多数の孔を持つ膜であれ
ば、任意の材質を使用することができる。The inner cylinder 2 is formed of a membrane through which a denatured protein solution can pass. In this embodiment, a cylindrical ceramic membrane is used, and the denatured protein solution can be injected into the inner cylinder 2 with a uniform flux from a myriad of points on the entire membrane surface. However, it is not necessary to allow the denatured protein solution to permeate the entire membrane surface, and any material can be used as long as the membrane has a large number of pores into which a highly viscous denatured protein solution can be injected without clogging. Can be.
【0013】このように反応槽である内筒2の内部にプ
ラグフローで再生液を流しながらその周囲から変性蛋白
質液を透過させれば、反応槽である内筒2の内部の変性
蛋白質の濃度は入口側では低く、取り出し口5が設けら
れた出口側に向かって次第に高くなる。ここで重要なこ
とは、反応槽中の変性蛋白質の濃度が入口側では低く、
出口側に向かって次第に高くなることであり、それを達
成するために必ずしも反応槽が1つである必要はなく、
いくつかの反応槽をつなげたような形でも良い。その結
果、前記した半回分法と同様に変性蛋白質の濃度の低い
部分で高効率で蛋白質の再生が行われる。そして反応槽
内の滞留時間を適切に設定することにより、中間体の凝
集を抑えながら液の混合を行うことができるので、高効
率の再生が可能となり、しかもこの方法によれば連続処
理もできる。As described above, if the denatured protein solution is permeated from the surroundings while the regenerating solution flows through the inside of the inner tube 2 as a reaction tank by a plug flow, the concentration of the denatured protein inside the inner tube 2 as a reaction tank can be increased. Is low on the inlet side and gradually increases toward the outlet side where the outlet 5 is provided. What is important here is that the concentration of denatured protein in the reaction vessel is low on the inlet side,
Gradually increasing toward the outlet side, it is not always necessary to have one reaction vessel to achieve that,
A form in which several reaction tanks are connected may be used. As a result, similar to the above-mentioned semi-batch method, the protein is regenerated with high efficiency in the portion where the concentration of the denatured protein is low. Then, by appropriately setting the residence time in the reaction tank, the liquid can be mixed while suppressing the aggregation of the intermediate, so that high-efficiency regeneration is possible, and according to this method, continuous processing is also possible. .
【0014】[0014]
【実施例】以下に本発明の実施例を示す。まず変性用緩
衝液(8M Urea,0.1M Tris-HCl,1mM EDTA,10mM DTT,pH8.
5) に30分間窒素を通気した後、所定の濃度になるよう
にリゾチームを加え、38℃で2 時間攪拌、インキュベー
トして変性蛋白質液を得た。この変性蛋白質液を図1に
示した再生装置を用いて再生した。この装置の内膜は外
径30mm、内径22mm、長さ120mm 、孔径2 μm のセラミッ
ク膜であり、その内部には再生用緩衝液(1.5M Urea,3mM
GSH,5mM GSSG,0.1M Tris-HCl,1mM EDTA,pH8.0) がプラ
グフローで流されている。変性蛋白質液はセラミック膜
を通して再生用緩衝液中に全膜面から均一なフラックス
で注入され、希釈された。Examples of the present invention will be described below. First, a denaturing buffer (8 M Urea, 0.1 M Tris-HCl, 1 mM EDTA, 10 mM DTT, pH 8.
After aeration of nitrogen for 5 minutes in 5), lysozyme was added to a predetermined concentration, and the mixture was stirred and incubated at 38 ° C for 2 hours to obtain a denatured protein solution. The denatured protein solution was regenerated using the regenerating device shown in FIG. The inner membrane of this device is a ceramic membrane with an outer diameter of 30 mm, an inner diameter of 22 mm, a length of 120 mm, and a pore diameter of 2 μm, and a regeneration buffer (1.5 M Urea, 3 mM
GSH, 5 mM GSSG, 0.1 M Tris-HCl, 1 mM EDTA, pH 8.0) is flowing through the plug flow. The denatured protein solution was injected through the ceramic membrane into the regeneration buffer from the entire membrane surface with a uniform flux and diluted.
【0015】取り出し口から取り出された流出液を20分
間ずつ240 分間サンプリングした。その後、サンプルを
緩やかに攪拌しながら24時間インキュベートし、活性及
び濃度測定を行い、最終的な再生効率を求めた。活性測
定は基質としてMicrococcus lysodeiktics dried cell
を用い、450nm の吸光度の減少速度から求めた。また濃
度測定は分光光度計を用いて行い、280nm における吸収
から求めた。再生効率は同濃度のネイティブなリゾチー
ムの活性に対する活性比から求めた。The effluent taken out from the outlet was sampled every 20 minutes for 240 minutes. Thereafter, the sample was incubated for 24 hours with gentle stirring, and the activity and concentration were measured to determine the final regeneration efficiency. The activity was measured using Micrococcus lysodeiktics dried cell as the substrate.
Was determined from the rate of decrease in absorbance at 450 nm. The concentration was measured using a spectrophotometer and determined from the absorption at 280 nm. The regeneration efficiency was determined from the activity ratio to the activity of native lysozyme at the same concentration.
【0016】なお装置の操作条件は、変性蛋白質液の流
量0.135mL/min,再生用緩衝液流量1.22mL/min, 攪拌羽根
の回転速度40rpm とし、定常状態において変性蛋白質液
が10倍に希釈されるように調節した。同操作条件におけ
る装置内の液混合は、Blue Dextran 2000 をトレーサー
としたステップ応答実験により求めた。The operating conditions of the apparatus were as follows: a denatured protein solution flow rate of 0.135 mL / min, a regeneration buffer solution flow rate of 1.22 mL / min, and a stirring blade rotation speed of 40 rpm. In a steady state, the denatured protein solution was diluted 10-fold. Was adjusted to The liquid mixing in the apparatus under the same operating conditions was determined by a step response experiment using Blue Dextran 2000 as a tracer.
【0017】ステップ応答実験より、槽列モデルにおい
て装置段数が3段であることが分かった。また反応槽内
の滞留時間は34分である。図2に半回分操作における変
性蛋白質添加時間の再生効率の影響を示した。このとき
半回分操作の添加時間と本法の滞留時間は同じ意味であ
る。その結果、30分以上で再生効率95%を達成し、本操
作条件が適切な滞留時間であることが分かる。図3に各
時間にサンプリングした再生蛋白質液の濃度及び再生効
率を示した。この時、変性蛋白質液にはリゾチーム濃度
15mg/mL のものを用いた。120 分以降定常状態となり、
リゾチーム濃度15mg/mL 、再生効率95%のほぼ均一な再
生蛋白質液が得られた。From the step response experiment, it was found that the number of stages in the tank row model was three. The residence time in the reactor is 34 minutes. FIG. 2 shows the influence of the regeneration time on the time of adding the denatured protein in the semi-batch operation. At this time, the addition time of the semi-batch operation and the residence time of the present method have the same meaning. As a result, a regeneration efficiency of 95% was achieved in 30 minutes or more, indicating that the operation conditions are appropriate residence times. FIG. 3 shows the concentration and the regeneration efficiency of the regenerated protein solution sampled at each time. At this time, the denatured protein solution contains lysozyme
The one at 15 mg / mL was used. After 120 minutes, steady state
An almost uniform regenerated protein solution having a lysozyme concentration of 15 mg / mL and a regenerating efficiency of 95% was obtained.
【0018】図4に、回分、半回分、本発明の連続操作
による再生効率の濃度依存性を示した。図示のとおり、
本発明の連続操作により従来の回分操作に比べ高く、半
回分操作と同等の再生効率が達成された。本発明の連続
操作は、装置段数が3段であっても、所期段階において
低濃度で再生を行うという半回分操作の効果を十分満た
しているためであると考えられる。FIG. 4 shows the concentration dependence of the regeneration efficiency by batch operation, semi-batch operation and continuous operation of the present invention. As shown,
With the continuous operation of the present invention, a regeneration efficiency higher than that of the conventional batch operation and equivalent to that of the semi-batch operation was achieved. It is considered that the continuous operation of the present invention sufficiently satisfies the effect of the half-time operation of performing the regeneration at a low concentration at the expected stage even when the number of the device stages is three.
【0019】[0019]
【発明の効果】以上に説明したように、本発明によれば
連続的に蛋白質の再生を行うことができ、しかも従来の
半回分操作と同等の高い再生効率を得ることができる。
このため本発明は、蛋白質の再生を工業的に実施するう
えで価値の高いものである。As described above, according to the present invention, protein can be continuously regenerated, and a high regenerating efficiency equivalent to the conventional half-batch operation can be obtained.
For this reason, the present invention is of high value in industrially performing protein regeneration.
【図1】本発明の装置を示す断面図である。FIG. 1 is a sectional view showing an apparatus of the present invention.
【図2】実施例における変性蛋白質液添加時間の再生効
率に与える影響を示すグラフである。FIG. 2 is a graph showing the effect of addition time of a denatured protein solution on regeneration efficiency in Examples.
【図3】実施例における再生蛋白質液の濃度及び再生効
率の経時変化を示すグラフである。FIG. 3 is a graph showing the time-dependent changes in the concentration of the regenerated protein solution and the regeneration efficiency in Examples.
【図4】実施例における再生効率の濃度依存性を示すグ
ラフである。FIG. 4 is a graph showing the concentration dependence of the regeneration efficiency in an example.
1 外筒、2 内筒、3 変性蛋白質液の供給口、4
再生液の供給口、5取り出し口、6 仕切り板、7 回
転軸、8 攪拌羽根1 outer cylinder, 2 inner cylinder, supply port for denatured protein solution, 4
Regeneration liquid supply port, 5 take-out port, 6 partition plate, 7 rotating shaft, 8 stirring blade
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B050 CC02 GG02 HH01 4H045 AA20 AA40 BA05 DA89 FA67 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4B050 CC02 GG02 HH01 4H045 AA20 AA40 BA05 DA89 FA67
Claims (5)
の反応槽中に変性蛋白質液を、その濃度が下流側に行く
ほど次第に高くなるように多数点から加えることを特徴
とする蛋白質の再生方法。1. A method for producing a protein, characterized in that a denatured protein solution is added from a number of points while flowing a regenerating solution inside the reaction tank such that the concentration of the denatured protein solution gradually increases toward the downstream side. Playback method.
均一フラックスで加える請求項1に記載の蛋白質の再生
方法。2. The method according to claim 1, wherein the denatured protein solution is supplied over the entire length of the reaction vessel.
The method for regenerating a protein according to claim 1, wherein the protein is added in a uniform flux.
に、変性蛋白質液を透過させることができる膜よりなる
内筒を設けるとともに、この内筒の一端に再生液の供給
口をまた他端に取り出し口を設け、さらにこの内筒の内
部に再生液を流すための仕切り板を配置したことを特徴
とする蛋白質の再生装置。3. An inner cylinder made of a membrane through which the denatured protein solution can pass is provided inside the outer cylinder to which the denatured protein solution is supplied, and a supply port for the regenerating solution is provided at one end of the inner cylinder. An apparatus for regenerating a protein, characterized in that a take-out port is provided at an end and a partition plate for flowing a regenerating solution is arranged inside the inner cylinder.
である請求項3に記載の蛋白質の再生装置。4. The protein regeneration device according to claim 3, wherein the inner cylinder is made of a porous ceramic membrane.
生液を攪拌する攪拌手段を配置した請求項3又は4に記
載の蛋白質の再生装置。5. The protein regenerating apparatus according to claim 3, wherein a stirring means for stirring the regenerating solution in a direction perpendicular to the flow direction is disposed inside the inner cylinder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11033640A JP2000229995A (en) | 1999-02-12 | 1999-02-12 | Method and apparatus for regenerating protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11033640A JP2000229995A (en) | 1999-02-12 | 1999-02-12 | Method and apparatus for regenerating protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000229995A true JP2000229995A (en) | 2000-08-22 |
Family
ID=12392059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11033640A Withdrawn JP2000229995A (en) | 1999-02-12 | 1999-02-12 | Method and apparatus for regenerating protein |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000229995A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003002590A3 (en) * | 2001-06-29 | 2003-05-01 | Anton Middelberg | A protein folding reactor |
-
1999
- 1999-02-12 JP JP11033640A patent/JP2000229995A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003002590A3 (en) * | 2001-06-29 | 2003-05-01 | Anton Middelberg | A protein folding reactor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3646195B2 (en) | Aqueous multiphase isolation of polypeptides. | |
| US6699706B1 (en) | Cell lysis method using a vortex mixer | |
| Yasuda et al. | Effect of additives on refolding of a denatured protein | |
| JP6099569B2 (en) | Composition and method for producing the same | |
| US4033817A (en) | Pressure-driven enzyme-coupled membranes | |
| EP3924487A1 (en) | Mrna purification by tangential flow filtration | |
| JPS6277332A (en) | Collection of protein | |
| US4678553A (en) | Renaturing reversibly denatured polypeptides and proteins by electrodialysis of solutions thereof in denaturants | |
| Mannen et al. | Expanded-bed protein refolding using a solid-phase artificial chaperone | |
| CN1608077A (en) | Method for renaturating proteins | |
| JP2000229995A (en) | Method and apparatus for regenerating protein | |
| JP2978518B2 (en) | Method for purifying phage DNA | |
| EP1645563A1 (en) | Protein-refolding material | |
| JP2001514362A (en) | Pump impeller and method of correcting the same | |
| Sur et al. | Enhancement of microfiltration of yeast suspensions using gas sparging–effect of feed conditions | |
| CN112522244B (en) | Dialysis method and application of inclusion body enriched solution of recombinant human tissue type plasminogen kinase derivative | |
| CN113456610B (en) | Manganese dioxide/sericin hybrid nanoparticle for resisting oxidative stress injury and preparation method thereof | |
| CN101273125B (en) | Enzyme production method | |
| Noritomi et al. | Efficient protein refolding using surfactants at high final protein concentration | |
| AU2004313698B2 (en) | Process for the purification of bacterially expressed proteins | |
| Katoh et al. | High yield refolding of lysozyme and carbonic anhydrase at high protein concentrations | |
| CN1410435A (en) | Method of inclusion body protein renaturation and purification at the same time | |
| CN1063235A (en) | Preparation of hyperpermeable polysulfone hollow fiber ultrafiltration membrane | |
| CN104862363B (en) | A kind of synthetic method of enzymatic benzyloxycarbonyl group-alanyl-glutamine | |
| CN120714326A (en) | Nano gel filtration material and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20060509 |